Research and Markets: ‘Advancing Molecular Diagnostics to Personalize Cancer Therapy’ report analyzes current and …
Research and Markets: ‘Advancing Molecular Diagnostics to Personalize Cancer Therapy’ report analyzes current and …
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/efa9a4/advancing_molecula) has announced the addition of the “Advancing Molecular Diagnostics to Personalize Cancer Therapy” report to their offering. This report analyzes current and potential world markets for key cancer-based molecular diagnostics, including advances in the …
Read more on Business Wire
Categories: Breast Cancer Information Tags: Advancing, analyzes, cancer, current, diagnostics, Markets, Molecular, Personalize, Report, research, Therapy
Dr., What Are The Current Indications For A Breast MRI?
Dr. Jennifer Engels, Breast Imaging Specialist at Cooper Clinic discusses the current indications for a breast MRI. Find more Breast Cancer treatment & information at www.EmpowHer.com. Share your story & send this to a friend.
Categories: Breast Cancer Treatment Tags: breast, current, indications
NASA Spaceline Current Awareness September 4, 2009
NASA Spaceline Current Awareness September 4, 2009
NASA Spaceline Current Awareness September 4, 2009
Read more on SpaceRef
Novelos Therapeutics Discontinues Current Development Program for NOV-002 in NSCLC
Novelos Therapeutics Discontinues Current Development Program for NOV-002 in NSCLC
NEWTON, Mass.—-Novelos Therapeutics, Inc. , a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that primary and secondary endpoints were not met in Novelos’ pivotal Phase 3 trial in advanced non-small cell lung cancer with its lead product, NOV-002, in combination with first-line chemotherapy.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Research Tags: current, Development, Discontinues, NOV002, Novelos, NSCLC, program, Therapeutics'